Caranx Medical

Caranx Medical is a French medical device company founded by Chief Marketing Officer Dr. Eric Sejor, Chief Technology Officer Dr. Pierre Berthet-Rayne, Dr. Philippe Pouletty, and Truffle Capital. Supported by a team of senior executives and experts, and backed by Truffle Capital, a leading European biotechnology and medical device investment firm, the company aims to become a global leader in the field of robot-assisted transcatheter heart valve implantation.Caranx Medical has developed TAVI PILOT, a simple-to-use robotic solution that provides precise, autonomous valve deployment and positioning. Caranx Medical's strategy includes the commercialization of TAVI PILOT Soft, an intraoperative navigation software that tracks anatomical and instrument landmarks on fluoroscopic images in real time, along with the TAVI PILOT robotic solution, which is expected to be tested in humans for the first time in 2025.